@conference{003a479f7c6746778464c9c53dc399ac,
title = "Graded prognostic assessment (GPA) of HER2 positive breast cancer patients with brain metastases.",
author = "Ming Chi and Venur, \{Vyshak Alva\} and Mohammadi, \{Alireza Mohammad\} and Chao, \{Samuel T.\} and Budd, \{G. Thomas\} and Montero, \{Alberto J.\} and Moore, \{Halle C. F.\} and Paul Elson and Suh, \{John H.\} and Lilyana Angelov and Barnett, \{Gene H.\} and Jame Abraham and Ahluwalia, \{Manmeet Singh\}",
note = "589 Background: Brain metastasis (BM) is a serious complication of HER2+ breast cancer (BC). We evaluated prognostic factors for overall survival (OS) in a contemporary cohort of patients (pts) with HER2+ BCBM treated at a tertiary care institution. Methods: The Cleveland Clinic's IRB approved BM database was used to identify HER2+ BCBM pts treated between 2000 and 2013.; Journal of Clinical Oncology ; Conference date: 01-01-2020",
year = "2015",
month = may,
day = "20",
doi = "10.1200/JCO.2015.33.15\_SUPPL.589",
language = "American English",
}